Evaluation of safety and efficacy for endoscopic biopsy using thin forceps

Evaluation of safety and efficacy for endoscopic biopsy using thin forceps - Safety and efficacy of thin forceps

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011140

Enrollment

100

Registered

2013-07-08

Start date

2013-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms in upper GI tract

Interventions

Endoscopic biopsy using thin forceps normal forceps Endoscopic biopsy using normal forceps

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (A)Scheduled endoscopic treatment of neoplasms in stomach or esophagus. (B)Neoplasm gross type is 0-IIa/IIb/IIc. (C)Demarcation line is detectable. (D)Informed consent. (E)Performance status(ECOG):0-2.

Exclusion criteria

Exclusion criteria: (A)Severe hematological, hepatological, or renal disorder accompanied with hemorrhagic tendency. (B)Other severe comorbidities. (C)During anticancer chemotherapy. (D)Poor compliance.

Design outcomes

Primary

Measure	Time frame
Rate of specimens which can be evaluated appropriately.	—

Secondary

Measure	Time frame
Endoscopic bleeding time.	—

Countries

Japan

Contacts

Public ContactSatoshi Ono

The University of Tokyo Hospital Department of Gastroenterology

satoshi-tky@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026